相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
Paola Cicconi et al.
CLINICAL INFECTIOUS DISEASES (2020)
An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis
Sebastian Aston-Deaville et al.
VACCINE (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
Amaka M. Awanye et al.
SCIENTIFIC REPORTS (2019)
Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S-aureus carriage and invasive disease
Elizaveta Elshina et al.
VACCINE (2019)
Assessment of Antibodies Induced by Multivalent Transmissions-Blocking Malaria Vaccines
Vinay Menon et al.
FRONTIERS IN IMMUNOLOGY (2018)
A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
Chuan Wang et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
Takuya Osada et al.
BREAST CANCER RESEARCH (2018)
Biological Functions of the Secretome of Neisseria meningitidis
Jan Tommassen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates
Jian Sha et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Dissection of the function of the RmpM periplasmic protein from Neisseria meningitidis
Sunil Maharjan et al.
MICROBIOLOGY-SGM (2016)
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
K. Ewer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
L. Marsay et al.
JOURNAL OF INFECTION (2015)
The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy
Christine S. Rollier et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
An Adenovirus-Vectored Nasal Vaccine Confers Rapid and Sustained Protection against Anthrax in a Single-Dose Regimen
Jianfeng Zhang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis
Muhammad Saleem et al.
PLOS ONE (2013)
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
George M. Warimwe et al.
VIROLOGY JOURNAL (2013)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch et al.
NATURE (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
The Iron-Repressed, AraC-Like Regulator MpeR Activates Expression of fetA in Neisseria gonorrhoeae
Aimee Hollander et al.
INFECTION AND IMMUNITY (2011)
Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
Sumi Biswas et al.
PLOS ONE (2011)
Review of Meningococcal Group B Vaccines
Dan M. Granoff
CLINICAL INFECTIOUS DISEASES (2010)
Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
Simon J. Draper et al.
JOURNAL OF IMMUNOLOGY (2010)
Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB
Mikio Tanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
Alexander D. Douglas et al.
VACCINE (2010)
Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung
Maria T. Arevalo et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
Johan Holst et al.
VACCINE (2009)
Effective induction of high-titer antibodies by viral vector vaccines
Simon J. Draper et al.
NATURE MEDICINE (2008)
A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis
Delin Zhu et al.
INFECTION AND IMMUNITY (2008)
Functional and specific antibody responses in adult volunteers in new Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines
E. Wedege et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone
V. Ann Stewart et al.
INFECTION AND IMMUNITY (2007)
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
DR Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Crystal structure of an anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design
CJ Oomen et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules
CAC Gioia et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal disease
J Holst et al.
VACCINE (2005)
The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis
TE Michaelsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen
YD Tan et al.
HUMAN GENE THERAPY (2003)
Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines
ZK Shi et al.
JOURNAL OF VIROLOGY (2001)
Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P-aeruginosa
BM Price et al.
INFECTION AND IMMUNITY (2001)
DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease
R Wallich et al.
INFECTION AND IMMUNITY (2001)
分享论文
